Menu Search
Equities

Croda International PLC

6CMB:DUS

Croda International PLC

Actions
  • Price (EUR)42.84
  • Today's Change0.43 / 1.01%
  • Shares traded--
  • 1 Year change-18.40%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Croda International Plc is a United Kingdom-based specialty chemicals company. The Company uses its smart science to create high performance ingredients and technologies that improve people's lives. Its sales, marketing and research activities are organized into three global market sectors: consumer care, life sciences and industrial specialties. Its consumer care sector's business units comprise beauty actives, fragrances and flavors, beauty care, and home care. It a has large actives portfolio across two ranges: Sederma Actives and Croda Botanicals. The beauty care delivers differentiated ingredients across skin, hair and solar care. The Company's life sciences sector's business units comprise agriculture (crop protection and seed enhancement) and pharma. The crop protection unit offers ingredients that improve performance and delivery of crop formulations. The pharma comprises three technology platforms: protein/small molecule delivery; adjuvant systems, and nucleic acid delivery.

  • Revenue in GBP (TTM)1.63bn
  • Net income in GBP162.70m
  • Incorporated1925
  • Employees5.85k
  • Location
    Croda International PLCCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.